Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants – BioSpaceBy / June 18, 2020 Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants BioSpace Share this:TweetReddit
